Matthew Harrison
Stock Analyst at Morgan Stanley
(3.44)
# 976
Out of 5,042 analysts
703
Total ratings
48.95%
Success rate
3.98%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Maintains: Equal-Weight | $144 → $149 | $149.89 | -0.59% | 55 | Oct 10, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $31 → $32 | $26.74 | +19.67% | 26 | Oct 10, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $761 → $756 | $577.95 | +30.81% | 56 | Oct 10, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $766 → $1,040 | $817.32 | +27.25% | 26 | Oct 1, 2025 | |
| DNLI Denali Therapeutics | Maintains: Overweight | $33 → $30 | $15.96 | +87.97% | 13 | Aug 18, 2025 | |
| INSM Insmed | Downgrades: Equal-Weight | $112 → $126 | $159.66 | -21.08% | 19 | Aug 13, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $81 → $83 | $31.86 | +160.51% | 13 | Aug 12, 2025 | |
| IOBT IO Biotech | Maintains: Overweight | $6 → $4 | $1.00 | +300.00% | 6 | Aug 12, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $460 → $439 | $421.39 | +4.18% | 41 | Aug 5, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Equal-Weight | $15 → $20 | $22.81 | -12.32% | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 → $96 | $54.48 | +76.21% | 22 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Positive | $215 | $161.31 | +33.28% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $130 → $135 | $120.94 | +11.63% | 42 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $3.21 | +87.21% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $1.66 | +201.20% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $152.86 | +16.45% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $32.63 | +71.62% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $29.28 | +87.84% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.50 | +100.00% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $24.15 | -54.45% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $1.71 | +367.84% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $3.72 | +88.17% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $22.99 | +47.89% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $29.89 | +7.06% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $5.33 | +256.47% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $2.23 | -55.16% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $17.71 | -43.53% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $9.20 | -13.04% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $32.02 | +37.41% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $5.59 | +132.56% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $17.64 | +353.51% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $6.00 | +900.00% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $105.66 | +104.43% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $4.09 | +22.25% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.79 | +179.31% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $227.99 | -20.17% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $18.69 | -51.85% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $53.77 | -25.61% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $291.76 | -3.35% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $463.43 | -54.69% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $24.76 | +110.02% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $190.40 | -9.14% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $33.53 | +257.89% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $16.60 | +791.57% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $87.49 | -6.28% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $43.83 | +50.58% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $4.75 | +721.05% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $37.26 | +23.46% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $9.16 | +282.10% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $825.45 | -66.68% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.39 | +694.98% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $13.03 | +375.83% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $16.07 | +7.34% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $91.28 | -9.07% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $57.83 | -82.71% | 4 | Sep 10, 2018 |
Biogen
Oct 10, 2025
Maintains: Equal-Weight
Price Target: $144 → $149
Current: $149.89
Upside: -0.59%
Moderna
Oct 10, 2025
Maintains: Equal-Weight
Price Target: $31 → $32
Current: $26.74
Upside: +19.67%
Regeneron Pharmaceuticals
Oct 10, 2025
Maintains: Overweight
Price Target: $761 → $756
Current: $577.95
Upside: +30.81%
argenx SE
Oct 1, 2025
Maintains: Overweight
Price Target: $766 → $1,040
Current: $817.32
Upside: +27.25%
Denali Therapeutics
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $15.96
Upside: +87.97%
Insmed
Aug 13, 2025
Downgrades: Equal-Weight
Price Target: $112 → $126
Current: $159.66
Upside: -21.08%
Legend Biotech
Aug 12, 2025
Maintains: Overweight
Price Target: $81 → $83
Current: $31.86
Upside: +160.51%
IO Biotech
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $1.00
Upside: +300.00%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $421.39
Upside: +4.18%
Sarepta Therapeutics
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $22.81
Upside: -12.32%
Jul 22, 2025
Maintains: Overweight
Price Target: $97 → $96
Current: $54.48
Upside: +76.21%
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $161.31
Upside: +33.28%
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $120.94
Upside: +11.63%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $3.21
Upside: +87.21%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $1.66
Upside: +201.20%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $152.86
Upside: +16.45%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $32.63
Upside: +71.62%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $29.28
Upside: +87.84%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.50
Upside: +100.00%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $24.15
Upside: -54.45%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $1.71
Upside: +367.84%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $3.72
Upside: +88.17%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $22.99
Upside: +47.89%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $29.89
Upside: +7.06%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $5.33
Upside: +256.47%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $2.23
Upside: -55.16%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $17.71
Upside: -43.53%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $9.20
Upside: -13.04%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $32.02
Upside: +37.41%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $5.59
Upside: +132.56%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $17.64
Upside: +353.51%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $6.00
Upside: +900.00%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $105.66
Upside: +104.43%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $4.09
Upside: +22.25%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.79
Upside: +179.31%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $227.99
Upside: -20.17%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $18.69
Upside: -51.85%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $53.77
Upside: -25.61%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $291.76
Upside: -3.35%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $463.43
Upside: -54.69%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $24.76
Upside: +110.02%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $190.40
Upside: -9.14%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $33.53
Upside: +257.89%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $16.60
Upside: +791.57%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $87.49
Upside: -6.28%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $43.83
Upside: +50.58%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $4.75
Upside: +721.05%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $37.26
Upside: +23.46%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $9.16
Upside: +282.10%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $825.45
Upside: -66.68%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.39
Upside: +694.98%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $13.03
Upside: +375.83%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $16.07
Upside: +7.34%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $91.28
Upside: -9.07%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $57.83
Upside: -82.71%